THU298 Effect Of SGLT2 Inhibition On Metabolic, Cardiac And Renal Outcomes In Heart Transplant Recipients (EMPA-HTx study): Protocol And Study Design

Disclosure: L.M. Raven: None. C.A. Muir: None. C. Kessler Iglesias: None. E. Kotlyar: None. K. Muthiah: None. N.K. Bart: Advisory Board Member; Self; Bristol-Myers Squibb. Grant Recipient; Self; Pfizer, Inc. Speaker; Self; Pfizer, Inc. P.S. Macdonald: Speaker; Self; Boehringer Ingelheim, AstraZeneca...

Descripción completa

Detalles Bibliográficos
Autores principales: Raven, Lisa M, Muir, Christopher A, Kessler Iglesias, Cassia, Kotlyar, Eugene, Muthiah, Kavitha, Bart, Nicole K, Macdonald, Peter S, Hayward, Christopher S, Jabbour, Andrew, Greenfield, Jerry R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Diabetes And Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555754/
http://dx.doi.org/10.1210/jendso/bvad114.733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555754/
http://dx.doi.org/10.1210/jendso/bvad114.733

Ejemplares similares